Arturo Colombo

Arturo Colombo serves as CEO at Colpharma. Colpharma operates in the medical devices sector with approximately 36.0 employees. The company is headquartered in Milan, Lombardy.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 1,717 executive contacts are available in Lombardy.
• • Our database includes 201,467 c suite-level executives.

Cloudflare DNS Magento 2 Community Adobe Marketing Cloud Adform Nginx Facebook Login (Connect) Google Font API Google Dynamic Remarketing Facebook Custom Audiences Mobile Friendly Apache Google Maps (Non Paid Users) Facebook Widget Paypal Google Maps Google Tag Manager Google Analytics WordPress.org DoubleClick Floodlight AI

medical equipment manufacturing aerosol diagnostic at home blood pressure monitors pulsometers thermometers insect repellents pest control mosquito repellents post-bite relief wellness products personal care ffp2 masks rehabilitation pain management magnetotherapy thermotherapy infant formula anti-mosquito technology afib detection technology relief products care services quality wellness biocompatibility testing non-contact thermometers environmental safety health monitoring pressure measurement temperature tracking safety guarantee clinical testing innovative healthcare home diagnostics blood circulation respiratory therapy preventive health dietary supplements safety technologies professional health tools medical equipment distribution it solutions for health user-friendly devices durable medical equipment local pharmacy services collaboration with healthcare professionals medical devices hospital & health care health wellness & fitness

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Arturo Colombo in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Colpharma.

Arturo Colombo's Position in the MessageCEO Database

• •Arturo Colombo is 1 of 1 verified executive contact we track at Colpharma.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,706 verified executive contacts in Lombardy are in the database.
• •17 verified contacts work at medical devices companies in the 36.0 employee range (same size as Colpharma).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated August 2026.

How do I reach Arturo Colombo directly?

Arturo Colombo's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Colpharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Arturo Colombo work for?

Arturo Colombo is CEO at Colpharma, a company in the medical devices sector with 36.0 employees. The company is based in Milan, Lombardy.

Can I pitch or sell to Arturo Colombo?

As CEO at Colpharma, Arturo Colombo is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Arturo Colombo directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Arturo Colombo in?

Arturo Colombo works in the medical devices industry as CEO at Colpharma. MessageCEO provides verified contact information for executives across all major industries.

Is Arturo Colombo's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Arturo Colombo's profile is kept up-to-date with the latest available information.

Last updated: August 24, 2026